Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001080916 | SCV000561195 | benign | Brugada syndrome | 2025-01-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000827827 | SCV000969490 | likely benign | not provided | 2021-04-29 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002489127 | SCV002806557 | likely benign | Brugada syndrome 2 | 2021-09-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003114601 | SCV003801103 | benign | not specified | 2023-01-14 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003960095 | SCV004771975 | likely benign | GPD1L-related disorder | 2024-01-16 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |